A detailed history of Johnson Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 6,036 shares of BMY stock, worth $333,670. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,036
Previous 3,244 86.07%
Holding current value
$333,670
Previous $175,000 42.86%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $112,378 - $147,948
2,792 Added 86.07%
6,036 $250,000
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $141,013 - $159,881
-2,939 Reduced 47.53%
3,244 $175,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $257,962 - $307,819
-5,321 Reduced 46.25%
6,183 $317,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $37,107 - $41,491
-641 Reduced 5.28%
11,504 $667,000
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $197,373 - $219,152
3,098 Added 34.24%
12,145 $776,000
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $84,305 - $95,621
-1,283 Reduced 12.42%
9,047 $627,000
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $9,655 - $11,433
-141 Reduced 1.35%
10,330 $743,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $665 - $393,343
-5,119 Reduced 32.84%
10,471 $805,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $270,509 - $297,925
3,725 Added 31.39%
15,590 $1.2 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $87,731 - $105,198
-1,427 Reduced 10.74%
11,865 $866,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $25,527 - $29,759
476 Added 3.71%
13,292 $828,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $53,253 - $62,379
-900 Reduced 6.56%
12,816 $759,000
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $73,425 - $79,960
-1,186 Reduced 7.96%
13,716 $917,000
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $150,842 - $169,653
-2,542 Reduced 14.57%
14,902 $941,000
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $90,074 - $102,070
-1,560 Reduced 8.21%
17,444 $1.08 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $134,213 - $148,726
-2,337 Reduced 10.95%
19,004 $1.15 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $472,383 - $552,263
8,617 Added 67.72%
21,341 $1.26 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $66,073 - $96,020
1,424 Added 12.6%
12,724 $709,000
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $14,123 - $18,422
-287 Reduced 2.48%
11,300 $725,000
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $24,678 - $29,259
-577 Reduced 4.74%
11,587 $587,000
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $38,239 - $42,284
-857 Reduced 6.58%
12,164 $552,000
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $12,678 - $15,117
-281 Reduced 2.11%
13,021 $621,000
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $27,841 - $36,104
571 Added 4.49%
13,302 $692,000
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $10,596 - $11,952
192 Added 1.53%
12,731 $790,000
Q2 2018

Aug 07, 2018

BUY
$50.53 - $62.98 $84,284 - $105,050
1,668 Added 15.34%
12,539 $694,000
Q1 2018

May 07, 2018

BUY
$59.92 - $68.98 $5,992 - $6,898
100 Added 0.93%
10,871 $687,000
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $9,350 - $10,194
-156 Reduced 1.43%
10,771 $660,000
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $603,498 - $696,486
10,927
10,927 $696,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.